financetom
Business
financetom
/
Business
/
International Paper' Medium-Term $4 Billion EBITDA Target Signals Potential Upside, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
International Paper' Medium-Term $4 Billion EBITDA Target Signals Potential Upside, RBC Says
Jul 25, 2024 12:50 PM

03:29 PM EDT, 07/25/2024 (MT Newswires) -- International Paper ( IP ) is highlighting an "enticing" potential upside with its $4 billion EBITDA target over the medium term, RBC Capital Markets said in a report Thursday.

The target is well above the FactSet consensus EBITDA of $2.9 billion for 2026, reflects the standalone International Paper ( IP ) portfolio, and does not represent a pro-forma target inclusive of the acquisition by the company of DS Smith, according to the investment firm.

"We came away from the Q2 earnings call with a positive view of the strength of management's conviction in its ability to drive better performance over the medium term through improving reliability, sharpening its focus on customer strategy and investments, and reducing its operating cost base," it said.

RBC said patience will be needed though as the company issued underwhelming Q3 guidance and signaled around three to four "choppy" quarters to come.

RBC reiterated its outperform rating on the stock as it raised its price target to $56 from $52.

Price: 46.36, Change: +0.07, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug
Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug
Jun 6, 2025
12:54 PM EDT, 06/06/2025 (MT Newswires) -- Phathom Pharmaceuticals ( PHAT ) shares jumped nearly 104% in recent Friday trading after the company said the US Food and Drug Administration approved its citizen petition to grant full New Chemical Entity exclusivity for its acid-reducing drug, Voquezna, or vonoprazan. The FDA confirmed it will update the Orange Book to reflect a...
Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing
Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing
Jun 6, 2025
12:45 PM EDT, 06/06/2025 (MT Newswires) -- Salvatore A Miosi, President & COO, on June 05, 2025, sold 30,000 shares in Mgic Investment ( MTG ) for $781,110. Following the Form 4 filing with the SEC, Miosi has control over a total of 694,245 common shares of the company, with 309,401 shares held directly and 384,844 controlled indirectly. SEC Filing:...
Viavi Solutions Insider Sold Shares Worth $761,842, According to a Recent SEC Filing
Viavi Solutions Insider Sold Shares Worth $761,842, According to a Recent SEC Filing
Jun 6, 2025
12:44 PM EDT, 06/06/2025 (MT Newswires) -- Ilan Daskal, Executive Vice President, CFO, on June 04, 2025, sold 82,095 shares in Viavi Solutions ( VIAV ) for $761,842. SEC Filing: https://www.sec.gov/Archives/edgar/data/912093/000091209325000075/xslF345X05/form4.xml Price: 9.46, Change: +0.15, Percent Change: +1.61 ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved